Status:
COMPLETED
Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan
Lead Sponsor:
University of Saskatchewan
Collaborating Sponsors:
Royal University Hospital Foundation
Conditions:
Unexplained Infertility
Polycystic Ovarian Syndrome
Eligibility:
All Genders
18-43 years
Brief Summary
The overall objective of this study is to determine whether serum BPA and/or phthalate concentrations differ in fertile versus infertile men and women in Saskatchewan. The investigators will test the ...
Detailed Description
Study Sample: Couples undergoing in vitro fertilization (IVF) and/or Intracytoplasmic Sperm Injection (ICSI) for assisted reproduction at ARTUS as well as healthy male and female volunteers 18-43 yea...
Eligibility Criteria
Inclusion
- Age: 18-43 years
- Couples undergoing IVF for:
- Unexplained infertility Male factor infertility Polycystic Ovary(PCOS)
- Both male and female partners must agree to participate
Exclusion
- Age: \<18 and \>43 years
- Couples with both male and female factor infertility
- Only female or male partner agrees to participate
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT02272439
Start Date
March 1 2012
End Date
January 1 2015
Last Update
December 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstretrics, Gynecology and Reproductive Science, RUH
Saskatoon, Saskatchewan, Canada, S7N0W8